| Bioactivity | HBV-IN-9 is a potent HBsAg (HBV Surface antigen) inhibitor (IC50=10 nM) and HBV DNA production inhibitor (IC50=0.15 nM in HepG2.2.15 cells)[1]. From patent WO2018001952A1, example 20. |
| Name | HBV-IN-9 |
| CAS | 2170998-69-1 |
| Formula | C22H24FN7O |
| Molar Mass | 421.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhanling CHENG, et al. Novel tetrahydropyridopyrimidines for the treatment and prophylaxis of hbv infection. WO2018001952A1. |
HBV-IN-9
CAS: 2170998-69-1 F: C22H24FN7O W: 421.47
HBV-IN-9 is a potent HBsAg (HBV Surface antigen) inhibitor (IC50=10 nM) and HBV DNA production inhibitor (IC50=0.15 nM i
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.